Sequential Bottlenecks Drive Viral Evolution in Early Acute Hepatitis C Virus Infection

English version České info

Hepatitis C is a pandemic human RNA virus, which commonly causes chronic infection and liver disease. The characterization of viral populations that successfully initiate infection, and also those that drive progression to chronicity is instrumental for understanding pathogenesis and vaccine design. A comprehensive and longitudinal analysis of the viral population was conducted in four subjects followed from very early acute infection to resolution of disease outcome. By means of next generation sequencing (NGS) and standard cloning/Sanger sequencing, genetic diversity and viral variants were quantified over the course of the infection at frequencies as low as 0.1%. Phylogenetic analysis of reassembled viral variants revealed acute infection was dominated by two sequential bottleneck events, irrespective of subsequent chronicity or clearance. The first bottleneck was associated with transmission, with one to two viral variants successfully establishing infection. The second occurred approximately 100 days post-infection, and was characterized by a decline in viral diversity. In the two subjects who developed chronic infection, this second bottleneck was followed by the emergence of a new viral population, which evolved from the founder variants via a selective sweep with fixation in a small number of mutated sites. The diversity at sites with non-synonymous mutation was higher in predicted cytotoxic T cell epitopes, suggesting immune-driven evolution. These results provide the first detailed analysis of early within-host evolution of HCV, indicating strong selective forces limit viral evolution in the acute phase of infection.

Vyšlo v časopise: Sequential Bottlenecks Drive Viral Evolution in Early Acute Hepatitis C Virus Infection. PLoS Pathog 7(9): e32767. doi:10.1371/journal.ppat.1002243
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.ppat.1002243

Souhrn

Zdroje

1. The Global Burden Of HepatitisCWG 2004 Global burden of disease (GBD) for hepatitis C. J Clin Pharmacol 44 20 29

2. AscioneATartaglioneTDi CostanzoGG 2007 Natural history of chronic hepatitis C virus infection. Dig Liv Dis 39 Suppl 1 S4 7

3. BowenDWalkerC 2005 Adaptive immune responses in acute and chronic hepatitis C virus infection. Nature 436 946 952

4. PostJRatnarajahSLloydAR 2009 Immunological determinants of the outcomes from primary hepatitis C infection. Cell Mol Life Sci 66 733 756

5. StricklandGEl-KamarySKlenermanPNicosiaA 2008 Hepatitis C vaccine: supply and demand. Lancet Infect Dis 8 379 386

6. MaherLWhiteBHellardMMaddenAPrinsM 2010 Candidate hepatitis C vaccine trials and people who inject drugs: challenges and opportunities. Vaccine 28 7273 7278

7. TorresiJJohnsonDWedemeyerH 2011 Progress in the development of preventive and therapeutic vaccines for hepatitis C virus. J Hepatol 54 1273 1285

8. SanjuanRMoyaAElenaSF 2004 The distribution of fitness effects caused by single-nucleotide substitutions in an RNA virus. Proc Natl Acad Sci U S A 101 8396 8401

9. NeumannAULamNPDahariHGretchDRWileyTE 1998 Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy. Science 282 103 107

10. GuedjJRongLDahariHPerelsonAS 2010 A perspective on modelling hepatitis C virus infection. J Viral Hepat 17 825 833

11. DuffySShackeltonLAHolmesEC 2008 Rates of evolutionary change in viruses: patterns and determinants. Nat Rev Genet 9 267 276

12. ElenaSFSanjuánR 2007 Virus evolution: insights from an experimental approach. Annu Rev Ecol Evol Syst 38 27 52

13. BoutwellCLRollandMMHerbeckJTMullinsJIAllenTM 2010 Viral evolution and escape during acute HIV-1 infection. J Infect Dis 202 Suppl 2 S309 314

14. BarKJLiHChamberlandATremblayCRoutyJP 2010 Wide variation in the multiplicity of HIV-1 infection among injection drug users. J Virol 84 6241 6247

15. KeeleBFGiorgiEESalazar-GonzalezJFDeckerJMPhamKT 2008 Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc Natl Acad Sci U S A 105 7552 7557

16. KouyosRDAlthausCLBonhoefferS 2006 Stochastic or deterministic: what is the effective population size of HIV-1? Trends Microbiol 14 507 511

17. KoelleKCobeySGrenfellBPascualM 2006 Epochal evolution shapes the phylodynamics of interpandemic influenza A (H3N2) in humans. Science 314 1898 1903

18. SheridanIPybusOGHolmesECKlenermanP 2004 High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression. J Virol 78 3447 3454

19. FarciPShimodaACoianaADiazGPeddisG 2000 The outcome of acute hepatitis C predicted by the evolution of the viral quasispecies. Science 288 339 344

20. ShankarappaRMargolickJBGangeSJRodrigoAGUpchurchD 1999 Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol 73 10489 10502

21. GoonetillekeNLiuMKSalazar-GonzalezJFFerrariGGiorgiE 2009 The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection. J Exp Med 206 1253 1272

22. Salazar-GonzalezJFSalazarMGKeeleBFLearnGHGiorgiEE 2009 Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection. J Exp Med 206 1273 1289

23. MarguliesMEgholmMAltmanWEAttiyaSBaderJS 2005 Genome sequencing in microfabricated high-density picolitre reactors. Nature 437 376 380

24. WangCMitsuyaYGharizadehBRonaghiMShaferRW 2007 Characterization of mutation spectra with ultra-deep pyrosequencing: application to HIV-1 drug resistance. Genome Res 17 1195 1201

25. WangGPCiuffiALeipzigJBerryCCBushmanFD 2007 HIV integration site selection: analysis by massively parallel pyrosequencing reveals association with epigenetic modifications. Genome Res 17 1186 1194

26. HoffmannCMinkahNLeipzigJWangGArensMQ 2007 DNA bar coding and pyrosequencing to identify rare HIV drug resistance mutations. Nucleic Acids Res 35 e91

27. LeTChiarellaJSimenBBHanczarukBEgholmM 2009 Low-abundance HIV drug-resistant viral variants in treatment-experienced persons correlate with historical antiretroviral use. PLoS One 4 e6079

28. TsibrisAMKorberBArnaoutRRussCLoCC 2009 Quantitative deep sequencing reveals dynamic HIV-1 escape and large population shifts during CCR5 antagonist therapy in vivo. PLoS One 4 e5683

29. JohnsonJALiJFWeiXLipscombJIrlbeckD 2008 Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naive populations and associate with reduced treatment efficacy. PLoS Med 5 e158

30. WangGPSherrill-MixSAChangKMQuinceCBushmanFD 2010 Hepatitis C virus transmission bottlenecks analyzed by deep sequencing. J Virol 84 6218 6228

31. SolmoneMVincentiDProsperiMCBrusellesAIppolitoG 2009 Use of massively parallel ultradeep pyrosequencing to characterize the genetic diversity of hepatitis B virus in drug-resistant and drug-naive patients and to detect minor variants in reverse transcriptase and hepatitis B S antigen. J Virol 83 1718 1726

32. Margeridon-ThermetSShulmanNSAhmedAShahriarRLiuT 2009 Ultra-deep pyrosequencing of hepatitis B virus quasispecies from nucleoside and nucleotide reverse-transcriptase inhibitor (NRTI)-treated patients and NRTI-naive patients. J Infect Dis 199 1275 1285

33. WrightCFMorelliMJThebaudGKnowlesNJHerzykP 2011 Beyond the consensus: dissecting within-host viral population diversity of Foot-and-Mouth Disease Virus by using next-generation genome sequencing. J Virol 85 2266 2275

34. ZagordiOKleinRDaumerMBeerenwinkelN 2010 Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res 38 7400 7409

35. FarciPPurcellRH 2000 Clinical significance of hepatitis C virus genotypes and quasispecies. Semin Liver Dis 20 103 126

36. ZagordiOGeyrhoferLRothVBeerenwinkelN 2010 Deep sequencing of a genetically heterogeneous sample: local haplotype reconstruction and read error correction. J Comput Biol 17 417 428

37. TimmJLauerGMKavanaghDGSheridanIKimAY 2004 CD8 epitope escape and reversion in acute HCV infection. J Exp Med 200 1593 1604

38. CoxALMosbrugerTLauerGMPardollDThomasDL 2005 Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C. Hepatology 42 104 112

39. CoxALMosbrugerTMaoQLiuZWangXH 2005 Cellular immune selection with hepatitis C virus persistence in humans. J Exp Med 201 1741 1752

40. ChenSWangYM 2007 Evolutionary study of hepatitis C virus envelope genes during primary infection. Chin Med J (Engl) 120 2174 2180

41. RaySCFanningLWangXHNetskiDMKenny-WalshE 2005 Divergent and convergent evolution after a common-source outbreak of hepatitis C virus. J Exp Med 201 1753 1759

42. TeutschSLucianiFScheuerNMcCredieLHosseinyP 2010 Incidence of primary hepatitis C infection and risk factors for transmission in an Australian prisoner cohort. BMC Public Health 10 633

43. DolanKTeutschSScheuerNLevyMRawlinsonW 2010 Incidence and risk for acute hepatitis C infection during imprisonment in Australia. Eur J Epidemiol 25 143 148

44. GiorgiEEFunkhouserBAthreyaGPerelsonASKorberBT Estimating time since infection in early homogeneous HIV-1 samples using a poisson model. BMC Bioinformatics 11 532

45. LeeHYGiorgiEEKeeleBFGaschenBAthreyaGS 2009 Modeling sequence evolution in acute HIV-1 infection. J Theor Biol 261 341 360

46. DrummondAJRambautAShapiroBPybusOG 2005 Bayesian coalescent inference of past population dynamics from molecular sequences. Mol Biol Evol 22 1185 1192

47. ZhangPZhongLStrubleEBWatanabeHKachkoA 2009 Depletion of interfering antibodies in chronic hepatitis C patients and vaccinated chimpanzees reveals broad cross-genotype neutralizing activity. Proc Natl Acad Sci U S A 106 7537 7541

48. OwsiankaAMTimmsJMTarrAWBrownRJHicklingTP 2006 Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding. J Virol 80 8695 8704

49. RuhlMKnuschkeTSchewiorKGlavinicLNeumann-HaefelinC 2011 The CD8+ T-Cell Response Promotes Evolution of Hepatitis C Virus Nonstructural Proteins. Gastroenterology 140 2064 2073

50. MeraniSPetrovicDJamesIChopraACooperD 2011 Effect of immune pressure on hepatitis C virus evolution: insights from a single-source outbreak. Hepatology 53 396 405

51. GaudieriSRauchAParkLPFreitasEHerrmannS 2006 Evidence of viral adaptation to HLA class I-restricted immune pressure in chronic hepatitis C virus infection. J Virol 80 11094 11104

52. TimmJLiBDanielsMGBhattacharyaTReyorLL 2007 Human leukocyte antigen-associated sequence polymorphisms in hepatitis C virus reveal reproducible immune responses and constraints on viral evolution. Hepatology 46 339 349

53. BuschMPGlynnSAWrightDJHirschkornDLaycockME 2005 Relative sensitivities of licensed nucleic acid amplification tests for detection of viremia in early human immunodeficiency virus and hepatitis C virus infection. Transfusion 45 1853 1863

54. FischerWGanusovVVGiorgiEEHraberPTKeeleBF 2010 Transmission of single HIV-1 genomes and dynamics of early immune escape revealed by ultra-deep sequencing. PLoS One 5 e12303

55. HaalandREHawkinsPASalazar-GonzalezJJohnsonATichacekA 2009 Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1. PLoS Pathog 5 e1000274

56. ZhuTMoHWangNNamDSCaoY 1993 Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261 1179 1181

57. Fafi-KremerSFofanaISoulierECarollaPMeulemanP 2010 Viral entry and escape from antibody-mediated neutralization influence hepatitis C virus reinfection in liver transplantation. J Exp Med 207 2019 2031

58. McCaffreyKBooIPoumbouriosPDrummerHE 2007 Expression and characterization of a minimal hepatitis C virus glycoprotein E2 core domain that retains CD81 binding. J Virol 81 9584 9590

59. MorelVFournierCFrancoisCBrochotEHelleF 2011 Genetic recombination of the hepatitis C virus: clinical implications. J Viral Hepat 18 77 83

60. HoltKEParkhillJMazzoniCJRoumagnacPWeillFX 2008 High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet 40 987 993

61. StifflerJDNguyenMSohnJALiuCKaplanD 2009 Focal distribution of hepatitis C virus RNA in infected livers. PLoS One 4 e6661

62. BartenschlagerRLohmannV 2000 Replication of hepatitis C virus. J Gen Virol 81 1631 1648

63. MaYYatesJLiangYLemonSMYiM 2008 NS3 helicase domains involved in infectious intracellular hepatitis C virus particle assembly. J Virol 82 7624 7639

64. BuschMP 2001 Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients. Transfus Clin Biol 8 200 206

65. GlynnSAWrightDJKleinmanSHHirschkornDTuY 2005 Dynamics of viremia in early hepatitis C virus infection. Transfusion 45 994 1002

66. Page-ShaferKPappalardoBLToblerLHPhelpsBHEdlinBR 2008 Testing strategy to identify cases of acute hepatitis C virus (HCV) infection and to project HCV incidence rates. J Clin Microbiol 46 499 506

67. PhamSTBullRABennettJMRawlinsonWDDoreGJ 2010 Frequent multiple hepatitis C virus infections among injection drug users in a prison setting. Hepatology 52 1564 1572

68. ZagordiOKleinRDaumerMBeerenwinkelN 2010 Error correction of next-generation sequencing data and reliable estimation of HIV quasispecies. Nucleic Acids Res 38 7400 7409

69. ZagordiOGeyrhoferLRothVBeerenwinkelN 2010 Deep sequencing of a genetically heterogeneous sample: local haplotype reconstruction and read error correction. J Comput Biol 17 417 428

70. KoboldtDCChenKWylieTLarsonDEMcLellanMD 2009 VarScan: variant detection in massively parallel sequencing of individual and pooled samples. Bioinformatics 25 2283 2285

71. GiorgiEEFunkhouserBAthreyaGPerelsonASKorberBT 2010 Estimating time since infection in early homogeneous HIV-1 samples using a poisson model. BMC Bioinformatics 11 532

72. SanjuanRNebotMRChiricoNManskyLMBelshawR 2010 Viral mutation rates. J Virol 84 9733 9748

73. TamuraKDudleyJNeiMKumarS 2007 MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 24 1596 1599

74. GuindonSGascuelO 2003 A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst Biol 52 696 704

75. PosadaDBuckleyTR 2004 Model selection and model averaging in phylogenetics: advantages of akaike information criterion and bayesian approaches over likelihood ratio tests. Syst Biol 53 793 808

76. DrummondAJRambautA 2007 BEAST: Bayesian evolutionary analysis by sampling trees. BMC Evol Biol 7 214